Active · per the CBE, 30 October 2026
AMYNAS logo

AMYNAS

BE0739947474

Rechtspersoon Private limited company 1 establishment

AMYNAS is a research organisation in Duffel. Private Limited, started on 23 December 2019, 1 establishment.

Euster 104, 2570 Duffel amynas.com [email protected]

Behind the company: ELIAC BVBA, ZOE Invest BV, BIOCELLCONSULTING LLC.

Active for

6 year, 10 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Negative equity NBB

    More debt than assets in 2 of the last 4 fiscal years.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

  • Tight liquidity NBB

    Cash and receivables cover 17 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

AMYNAS from Duffel, company number BE0739947474, closed financial year 2025 with a result of € -847,982 after tax. For that financial year AMYNAS recorded a gross margin of € 24,753 and equity of € -272,136. Compared with financial year 2024, the result moved from € -992,358 to € -847,982. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Caution

€ -272,136

▼ € 197,982 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -847,982

▲ 15 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 23,010

▼ 86% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -2.8 million.

People and assets in 2025

Wage cost

€ 317,081

▼ 10% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 216,140

▲ € 163,713 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 15,164

▼ 66% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 435,158 € 510,630 € 242,283 € 24,753 ▼ 90%
Profit after taxes € -187,550 € -539,533 € -992,358 € -847,982 ▲ € 144,377
Equity € 207,737 € 768,204 € -74,155 € -272,136 ▼ € 197,982
Total debts € 79,673 € 138,655 € 248,540 € 327,031 ▲ 32%
Cash € 279,676 € 734,203 € 161,490 € 23,010 ▼ 86%
Retained profit € -402,263 € -941,796 € -1,934,155 € -2,782,136 ▼ € 847,982
Balance sheet total € 287,410 € 906,859 € 174,386 € 54,895 ▼ 69%

Key figures of AMYNAS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to AMYNAS?

What happened at AMYNAS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 847,982. Source: NBB ↗
  • ZOE Invest BV became a director. NBB
  • New establishment in Duffel. KBO
  • Start of the company according to the CBE. KBO
  • ELIAC BVBA became a director. NBB
  • BIOCELLCONSULTING LLC became a director. NBB

In short

From € 187,550 loss in 2022 to € 847,982 loss in 2025.

Management

Zoe Invest 25.3%

The stake of Zoe Invest comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

AMYNAS

Behind AMYNAS are ELIAC BVBA, ZOE Invest BV and BIOCELLCONSULTING LLC. The shares are held by Zoe Invest (25.3%).

Directors

According to the 2025 annual accounts

ELIAC BVBA

Director · represented by Verheye Stefan

since 2019

ZOE Invest BV

Director · represented by Segers Bart

Also active at: DISTRILINK

since 2020

BIOCELLCONSULTING LLC

Director · represented by Debrabandere Lode

since 2019

Shareholders

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Euster 104

2570 Duffel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

Advanced Custom FieldsLodashPWAReactWixlazysizes

Hosting & Email

Email provider

Self-hosted

Hosting

WIX_COM, IL

Domain

Domain

amynas.com

Registered

2019-09-10

Registrar

GoDaddy.com, LLC

Expires

2026-09-10

Website info

HTTPS Ja
Languages NL

Features

Webshop

Security

✓ HTTPS
✓ SPF
✗ DMARC

Network

✓ Load balancing

Details

Company number
0739.947.474
VAT number
BE 0739.947.474
Registered office
Euster 104, 2570 Duffel
Names & denominations
AMYNAS
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
23 December 2019
Peppol
Active · Active since 21 Oct 2025
Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Frequently asked questions

What does AMYNAS do?
AMYNAS is a research organisation in Duffel. Private Limited, started on 23 December 2019, 1 establishment.
What is the address of AMYNAS?
The registered office of AMYNAS is located at Euster 104, 2570 Duffel.
Is AMYNAS still active?
Yes. According to the CBE (30 October 2026) AMYNAS is active, legal situation “Normale toestand”, started on 23 December 2019.
Is AMYNAS registered on Peppol?
Yes, AMYNAS is registered on the Peppol network with ID 0208:0739947474.
What is the enterprise number of AMYNAS?
The enterprise number of AMYNAS is BE0739947474.
When was AMYNAS founded?
AMYNAS was founded on 23 December 2019.